ADAMTS13 and deep vein thrombosis: DVT patients carrying at least one rare ADAMTS13 variant showed a reduction of ADAMTS13 activity levels, which was more pronounced considering variants predicted to be damaging (ß -25.9%, 95% CI -36.0, -16.0), in agreement with our previous study [8].